Project code
|
Project Title
|
Commencement date
|
Value
|
Pre-requisite Units
|
Project Contact
|
| 1068 |
To determine the role of tissue type plasminogen activator (t-PA) in the progression and severity of multiple sclerosis
|
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
A/Prof Robert L Medcalf
Robert.Medcalf@monash.edu
|
| 1069 |
To identify the domain in the tissue-type plasminogen activator molecule required to modulate blood brain barrier permeability using an in vitro model |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
A/Prof Robert L Medcalf
Robert.Medcalf@monash.edu
|
|
1070
|
Manipulation of the plasmin-antiplasmin system to dissolve blood clots |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
A/Prof Paul Coughlin & Dr Anita Horvath
Paul.Coughlin@monash.edu
Anita.Horvath@monash.edu
|
| 1071 |
Investigate the interaction of plasmin kringle domains with the antiplasmin |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
A/Prof Paul Coughlin & Dr Anita Horvath
Paul.Coughlin@monash.edu
Anita.Horvath@monash.edu
|
| 1072 |
Physiological and pathological significance of receptor shedding from platelets, and assessment of plasma soluble GPVI as a biomarker of thrombotic abnormalities |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Elizabeth Gardiner
Elizabeth.Gardiner@monash.edu
|
| 1073 |
In cold blood - the trouble with transfusion platelets |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Jane Arthur
Jane.Arthur@monash.edu
|
| 1074 |
Identification of binding sites for GPIb-IX-V ligands, and how these interactions regulate cell adhesion and coagulation |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Robert Andrews
Robert.Andrews@monash.edu
|
| 1075 |
Investigating new approaches to dissolve blood clots |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Simone M Schoenwaelder & Prof Shaun P Jackson
Simone.Schoenwaelder@monash.edu
|
| 1076 |
Investigating a new anti-clotting approach: Regulation of platelet adhesion and thrombus formation by the GPIb/V/IX adhesion receptor |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Sue Cranmer
Sue.Cranmer@monash.edu
|
| 1077 |
Investigation of the functional interplay between platelets and neutrophils |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Yuping
Yuanyuping.yuan@monash.edu
|
| 1078 |
Defining the function of thrombin receptors on human platelets during thrombosis |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Justin Hamilton
Justin.Hamilton@monash.edu
|
| 1079 |
Investigation of the effects of new anti-cancer agents on platelet function: A role for apoptosis in regulating platelet reactivity |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Prof Shaun Jackson & Dr Simone Schoenwaelder
Shaun.Jackson@monash.edu
Simone.Schoenwaelder@monash.edu
|
| 1080 |
A New Class of Antithrombotic Agents Investigating the role of PI 3-kinases in haemostasis and thrombosis |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Prof Shaun Jackson
Shaun.Jackson@monash.edu
|
| 1081 |
Investigating platelet hyperactivity in Diabetes |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Prof Shaun Jackson
Shaun.Jackson@monash.edu
|
| 1082 |
Targeting P13-Kinases in leukaemic cells: Looking for partners in crime |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Julie McManus & Dr Andrew Wei
Ju.McManus@alfred.org.au
|
| 1083 |
The effect of novel anti-cancer drugs on the ability of bone marrow stroma to support acute myeloid leukaemia survival and proliferation |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Andrew Wei
andrew.wei@alfred.org.au
|
| 1084 |
Androgens: more strings to the bow. Understanding androgen mediated erythropoiesis. |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Julie McManus & Dr Andrew Wei
Ju.McManus@alfred.org.au
|
| 1085 |
What turns you on? Determining activation signals for platelets during thrombosis |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Justin Hamilton
Justin.Hamilton@monash.edu
|
| 1086 |
Sirtuins: Novel therapeutic targets for Multiple Myeloma |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Tiffany Khong
T.Khong@alfred.org.au
|
| 1087 |
Targeting heat shock response as a potential therapeutic target in multiple myeloma |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Tiffany Khong
T.Khong@alfred.org.au
|
| 1088 |
Haematopoietic and Leukemia Stem Cell Self-Renewal via Asymmetric Cell Division |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Stephen Ting
Stephen.Ting@monash.edu
|
| 1089 |
Anti-leukemic Effects and Molecular Mechanisms of Action of Novel Histone Deacetylase Inhibitors and Demethylating Agents in In vitro and In vivo Models of Myelodysplastic Syndrome |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Anthony Dear
anthony.dear@monash.edu
|
| 1090 |
Histone Deacetylase Inhibitors as Novel Treatments for Vascular Disease |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Dr Anthony Dear
anthony.dear@monash.edu
|
| 1091 |
Understanding how CD4 regulatory T cell development in the thymus is controlled |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Prof Steve Gerondakis & Dr George Grigoriadis
Steven.gerondakis@monash.edu
|
| 1092 |
Exactly what role does the NF-kappaB pathway play in multiple myeloma? |
21/11/10 (start dates flexible) |
$250 x 6-10 weeks ($1,500-$2,500 total)
|
None |
Prof Steve Gerondakis & Dr George Grigoriadis
Steven.gerondakis@monash.edu
|
